The drugs that have cancer on the run
Checkpoint inhibitors offer another approach for tackling advanced melanoma
27th August 2018
Attempts to improve the survival of patients with advanced or metastatic melanoma have, until recently, proven futile.
A CTLA-4 protein. CTLA4-blocking antibodies are used in cancer therapy (immune checkpoint blockade therapy). Photo: Alamy
However, emerging targeted therapies and immune checkpoint inhibitors induce high response rates and